User characteristics and outcomes from a national digital mental health service: an observational study of registrants of the Australian MindSpot Clinic.


Journal

The Lancet. Digital health
ISSN: 2589-7500
Titre abrégé: Lancet Digit Health
Pays: England
ID NLM: 101751302

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 26 10 2020
pubmed: 27 10 2020
medline: 27 10 2020
Statut: ppublish

Résumé

Interest is growing in digital and telehealth delivery of mental health services, but data are scarce on outcomes in routine care. The federally funded Australian MindSpot Clinic provides online and telephone psychological assessment and treatment services to Australian adults. We aimed to summarise demographic characteristics and treatment outcomes of patients registered with MindSpot over the first 7 years of clinic operation. We used an observational design to review all patients who registered for assessment with the MindSpot Clinic between Jan 1, 2013, and Dec 31, 2019. We descriptively analysed the demographics, service preferences, and baseline symptoms of patients. Among patients enrolled in a digital treatment course, we evaluated scales of depression (Patient Health Questionnaire-9 [PHQ-9]) and anxiety (Generalized Anxiety Disorder 7-Item Scale [GAD-7]), as primary measures of treatment outcome, from the screening assessment to post-treatment and a 3 month follow-up. The Kessler Psychological Distress 10-Item Plus Scale was also used to assess changes in general distress and disability, and course satisfaction was measured post-treatment. A total of 121 652 screening assessments were started, of which 96 018 (78·9%) were completed. The mean age of patients was 35·7 years (SD 13·8) and 88 702 (72·9%) were women. Based on available assessment data, 36 866 (34·5%) of 106 811 participants had never previously spoken to a health professional about their symptoms, and most people self-reported symptoms of anxiety (88 879 [81·9%] of 108 494) or depression (78 803 [72·6%] of 108 494), either alone or in combination, at baseline. 21 745 patients started treatment in a therapist-guided online course, of whom 14 503 (66·7%) completed treatment (≥four of five lessons). Key trends in service use included an increase in the proportion of people using MindSpot primarily for assessment and information, from 52·6% in 2013 to 66·7% in 2019, while the proportion primarily seeking online treatment decreased, from 42·6% in 2013 to 26·7% in 2019. Effect sizes and percentage changes were large for estimated mean scores on the PHQ-9 and GAD-7 from assessment to post-treatment (PHQ-9, Cohen's d effect size 1·40 [95% CI 1·37-1·43]; and GAD-7, 1·45 [1·42-1·47]) and the 3 month follow-up (PHQ-9, 1·36 [1·34-1·38]; and GAD-7, 1·42 [1·40-1·44]); proportions of patients with reliable symptom deterioration (score increase of ≥6 points [PHQ-9] or ≥5 points [GAD-7]) were low post-treatment (of 13 058 respondents, 184 [1·4%] had symptom deterioration on the PHQ-9 and 282 [2·2%] on the GAD-7); and patient satisfaction rates were high (12 452 [96·6%] of 12 895 respondents would recommend the course and 12 433 [96·7%] of 12 860 reported the course worthwhile). We also observed small improvements in disability following treatment as measured by days out of role. Our findings indicate improvement in psychological symptoms and positive reception among patients receiving online mental health treatment. These results support the addition of digital services such as MindSpot as a component in contemporary national mental health systems. None.

Sections du résumé

Background
Interest is growing in digital and telehealth delivery of mental health services, but data are scarce on outcomes in routine care. The federally funded Australian MindSpot Clinic provides online and telephone psychological assessment and treatment services to Australian adults. We aimed to summarise demographic characteristics and treatment outcomes of patients registered with MindSpot over the first 7 years of clinic operation.
Methods
We used an observational design to review all patients who registered for assessment with the MindSpot Clinic between Jan 1, 2013, and Dec 31, 2019. We descriptively analysed the demographics, service preferences, and baseline symptoms of patients. Among patients enrolled in a digital treatment course, we evaluated scales of depression (Patient Health Questionnaire-9 [PHQ-9]) and anxiety (Generalized Anxiety Disorder 7-Item Scale [GAD-7]), as primary measures of treatment outcome, from the screening assessment to post-treatment and a 3 month follow-up. The Kessler Psychological Distress 10-Item Plus Scale was also used to assess changes in general distress and disability, and course satisfaction was measured post-treatment.
Outcomes
A total of 121 652 screening assessments were started, of which 96 018 (78·9%) were completed. The mean age of patients was 35·7 years (SD 13·8) and 88 702 (72·9%) were women. Based on available assessment data, 36 866 (34·5%) of 106 811 participants had never previously spoken to a health professional about their symptoms, and most people self-reported symptoms of anxiety (88 879 [81·9%] of 108 494) or depression (78 803 [72·6%] of 108 494), either alone or in combination, at baseline. 21 745 patients started treatment in a therapist-guided online course, of whom 14 503 (66·7%) completed treatment (≥four of five lessons). Key trends in service use included an increase in the proportion of people using MindSpot primarily for assessment and information, from 52·6% in 2013 to 66·7% in 2019, while the proportion primarily seeking online treatment decreased, from 42·6% in 2013 to 26·7% in 2019. Effect sizes and percentage changes were large for estimated mean scores on the PHQ-9 and GAD-7 from assessment to post-treatment (PHQ-9, Cohen's d effect size 1·40 [95% CI 1·37-1·43]; and GAD-7, 1·45 [1·42-1·47]) and the 3 month follow-up (PHQ-9, 1·36 [1·34-1·38]; and GAD-7, 1·42 [1·40-1·44]); proportions of patients with reliable symptom deterioration (score increase of ≥6 points [PHQ-9] or ≥5 points [GAD-7]) were low post-treatment (of 13 058 respondents, 184 [1·4%] had symptom deterioration on the PHQ-9 and 282 [2·2%] on the GAD-7); and patient satisfaction rates were high (12 452 [96·6%] of 12 895 respondents would recommend the course and 12 433 [96·7%] of 12 860 reported the course worthwhile). We also observed small improvements in disability following treatment as measured by days out of role.
Interpretation
Our findings indicate improvement in psychological symptoms and positive reception among patients receiving online mental health treatment. These results support the addition of digital services such as MindSpot as a component in contemporary national mental health systems.
Funding
None.

Identifiants

pubmed: 33103097
doi: 10.1016/S2589-7500(20)30224-7
pii: S2589-7500(20)30224-7
pmc: PMC7571905
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e582-e593

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Aust N Z J Psychiatry. 2017 Dec;51(12):1227-1239
pubmed: 27733709
Australas Psychiatry. 2019 Aug;27(4):352-357
pubmed: 30058351
J Affect Disord. 2019 Sep 1;256:103-109
pubmed: 31170620
Internet Interv. 2020 Sep;21:100327
pubmed: 32537424
JMIR Ment Health. 2018 Apr 19;5(2):e22
pubmed: 29674311
J Anxiety Disord. 2015 Oct;35:88-102
pubmed: 26422822
J Ment Health. 2020 May 12;:1-10
pubmed: 32394756
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
World Psychiatry. 2017 Feb;16(1):90-99
pubmed: 28127925
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795
World Psychiatry. 2020 Jun;19(2):129-130
pubmed: 32394569
Aust Health Rev. 2014 Feb;38(1):80-5
pubmed: 24308925
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Lancet. 2018 Feb 17;391(10121):679-686
pubmed: 29224931
Aust N Z J Psychiatry. 2018 May;52(5):483-490
pubmed: 29325437
BMC Psychiatry. 2020 Mar 11;20(1):111
pubmed: 32160913
Psychol Med. 2011 Aug;41(8):1751-61
pubmed: 21134315
World Psychiatry. 2014 Feb;13(1):4-11
pubmed: 24497236
Aust N Z J Psychiatry. 2020 Jan;54(1):12-14
pubmed: 31852237
Epidemiology. 2010 Jul;21(4):467-74
pubmed: 20220526
Internet Interv. 2018 Jul 26;13:108-115
pubmed: 30206525
J Ment Health Policy Econ. 2017 Dec 1;20(4):155-166
pubmed: 29300702
Cogn Behav Ther. 2020 Jul;49(4):307-326
pubmed: 31553266
J Anxiety Disord. 2015 Dec;36:63-77
pubmed: 26460536
BJPsych Open. 2016 Sep 14;2(5):307-313
pubmed: 27703794
Psychiatr Serv. 2015 Oct;66(10):1043-50
pubmed: 26130001
J Clin Med. 2019 Aug 17;8(8):
pubmed: 31426460
Aust N Z J Psychiatry. 2011 Sep;45(9):726-39
pubmed: 21888609
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
JMIR Ment Health. 2018 Jul 12;5(3):e10200
pubmed: 30001999
BMC Psychiatry. 2015 Dec 01;15:304
pubmed: 26626712

Auteurs

Nickolai Titov (N)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.
Department of Psychology, Macquarie University, Sydney, NSW, Australia.

Blake F Dear (BF)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.
Department of Psychology, Macquarie University, Sydney, NSW, Australia.

Olav Nielssen (O)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Bethany Wootton (B)

Discipline of Clinical Psychology, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.

Rony Kayrouz (R)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Eyal Karin (E)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Ben Genest (B)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

James Bennett-Levy (J)

University Centre for Rural Health, The University of Sydney, NSW, Australia.

Carol Purtell (C)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Greg Bezuidenhout (G)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Rheza Tan (R)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Casey Minissale (C)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Priti Thadhani (P)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Nick Webb (N)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Simon Willcock (S)

Macquarie University Health Sciences Centre, Macquarie University, Sydney, NSW, Australia.

Gerhard Andersson (G)

Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden.
Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Heather D Hadjistavropoulos (HD)

Department of Psychology, University of Regina, Regina, SK, Canada.

David C Mohr (DC)

Center for Behavioral Intervention Technologies, Department of Preventive Medicine, Northwestern University, Chicago, IL, USA.

David J Kavanagh (DJ)

Centre for Children's Health Research and School of Psychology and Counselling, Queensland University of Technology, Brisbane, QLD, Australia.

Shane Cross (S)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Lauren G Staples (LG)

MindSpot Clinic, Macquarie University, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH